MiR-338-3p suppresses invasion of liver cancer cell by targeting smoothened

Journal of Pathology

Volumn 225, Issue 3, 2011, Pages 463-472

  Huang, Xiao Hui ^a   Chen, Jing Song ^a,b   Wang, Qian ^a   Chen, Xi Lin ^a   Wen, Li ^a   Chen, Lian Zhou ^a   Bi, Jiong ^a   Zhang, Long Juan ^a   Su, Qiao ^a   Zeng, Wen Tao ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b First Affiliated Hospital of Guangzhou   (China)

Author keywords

invasion; liver cancer; miR 338 3p; SMO; smoothened

Indexed keywords

GELATINASE B; MICRORNA; MICRORNA 338 3P; SMALL INTERFERING RNA; SMOOTHENED PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CANCER; METASTASIS; PRIORITY JOURNAL;

CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 9; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 80054725322     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2877     Document Type: Article

References (53)

1. Tan A, Yeh SH, Liu CJ, et al., Viral hepatocarcinogenesis: from infection to cancer. Liver Int 2008; 28: 175-188. (Pubitemid 351201032)
2. Yang L, Parkin DM, Ferlay J, et al., Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 2005; 14: 243-250. (Pubitemid 40165308)
3. Chen XP, Qiu FZ, Wu ZD, et al., Long-term outcome of resection of large hepatocellular carcinoma. Br J Surg 2006; 93: 600-606.
4. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
5. Hagan JP, Croce CM,. MicroRNAs in carcinogenesis. Cytogenet Genome Res 2007; 118: 252-259. (Pubitemid 350125264)
6. Calin GA, Croce CM,. MicroRNA signatures in human cancers. Nature Rev Cancer 2006; 6: 857-866. (Pubitemid 44629897)
7. Barbarotto E, Schmittgen TD, Calin GA,. MicroRNAs and cancer: profile, profile, profile. Int J Cancer 2008; 122: 969-977. (Pubitemid 351213993)
8. Murakami Y, Yasuda T, Saigo K, et al., Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006; 25: 2537-2545.
9. Huang YS, Dai Y, Yu XF, et al., Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J Gastroenterol Hepatol 2008; 23: 87-94. (Pubitemid 350265207)
10. Varnholt H, Drebber U, Schulze F, et al., MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 2008; 47: 1223-1232. (Pubitemid 351547908)
11. Ma L, Teruya-Feldstein J, Weinberg RA,. Tumor invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682-688. (Pubitemid 47552092)
12. Huang Q, Gumireddy K, Schrier M, et al., The microRNAs miR-373 and miR-520c promote tumor invasion and metastasis. Nature Cell Biol 2008; 10: 202-210. (Pubitemid 351194050)
13. Tavazoie SF, Alarcõn C, Oskarsson T, et al., Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451: 147-152.
14. Hurst DR, Edmonds MD, Scott GK, et al., Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 2009; 69: 1279-1283.
15. Gramantieri L, Fornari F, Callegari E, et al., MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med 2008; 12: 2189-2204.
16. Meng F, Henson R, Wehbe-Janek H, et al., MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647-658. (Pubitemid 47187346)
17. Ji J, Shi J, Budhu A, et al., MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009; 361: 1437-1447.
18. Kota J, Chivukula RR, O'Donnell KA, et al., Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009; 137: 1005-1017.
19. Huang XH, Wang Q, Chen JS, et al., Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. Hepatol Res 2009; 39: 786-794.
20. Berman DM, Karhadkar SS, Maitra A, et al., Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumors. Nature 2003; 425: 846-851. (Pubitemid 37351469)
21. Thayer SP, di Magliano MP, Heiser PW, et al., Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003; 425: 851-856. (Pubitemid 37355945)
22. Watkins DN, Berman DM, Burkholder SG, et al., Hedgehog signaling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003; 422: 313-317. (Pubitemid 36378358)
23. Yoo YA, Kang MH, Kim JS, et al., Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-mediated activation of the ALK5-Smad 3 pathway. Carcinogenesis 2008; 29: 480-490. (Pubitemid 351404863)
24. Cheng WT, Xu K, Tian DY, et al., Role of Hedgehog signaling pathway in proliferation and invasiveness of hepatocellular carcinoma cells. Int J Oncol 2009; 34: 829-836.
25. Chen JK, Taipale J, Young KE, et al., Small molecule modulation of Smoothened activity. Proc Natl Acad Sci U S A 2002; 99: 14071-14076. (Pubitemid 35257626)
26. Giannelli G, Bergamini C, Marinosci F, et al., Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma. Int J Cancer 2002; 97: 425-431. (Pubitemid 34027799)
27. Giannelli G, Fransvea E, Bergamini C, et al., Laminin-5 chains are expressed differentially in metastatic and nonmetastatic hepatocellular carcinoma. Clin Cancer Res 2003; 9: 3684-3691. (Pubitemid 37169236)
28. Fransvea E, Angelotti U, Antonaci S, et al., Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells. Hepatology 2008; 47: 1557-1566. (Pubitemid 351702739)
29. Chen JS, Huang XH, Wang Q, et al., FAK is involved in invasion and metastasis of hepatocellular carcinoma. Clin Exp Metastasis 2010; 27: 71-82.
30. Attiga FA, Fernandez PM, Weeraratna AT, et al., Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res 2000; 60: 4629-4637. (Pubitemid 32103650)
31. Cheng J, Huo DH, Kuang DM, et al., Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells. Cancer Res 2007; 67: 5141-5147. (Pubitemid 46997250)
32. Zhang Z, Zhou XY, Shen HJ, et al., Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study. BMC Med 2009; 7: 41.
33. Chiang AC, Massagué J,. Molecular basis of metastasis. N Engl J Med 2008; 359: 2814-2823.
34. Nabeshima K, Inoue T, Shimao Y, et al., Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Int 2002; 52: 255-264. (Pubitemid 34587810)
35. Overall CM, Kleifeld O,. Tumour microenvironment opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nature Rev Cancer 2006; 6: 227-239. (Pubitemid 43292566)
36. Egeblad M, Werb Z,. New functions for the matrix metalloproteinases in cancer progression. Nature Rev Cancer 2002; 2: 161-174. (Pubitemid 37328786)
37. Gramantieri L, Fornari F, Callegari E, et al., MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med 2008; 12: 2189-2204.
38. Coulouarn C, Factor VM, Andersen JB, et al., Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 2009; 8: 3526-3536.
39. Wong CC, Wong CM, Tung EK, et al., The micoRNA MiR-139 suppresses metastasis and progression of hepatocellular carcinoma by downregulating Rho-kinase 2. Gastroenterology 2010; DOI:10.1053/j.gastro.2010.10.006.
40. Zhang J, Yang Y, Yang T, et al., MicroRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer 2010; 12: 1215-1220.
41. Liang L, Wong CM, Ying Q, et al., MicroRNA-125b suppressed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology 2010; 52: 1731-1740.
42. Rodriguez A, Griffiths-Jones S, Ashurst JL, et al., Identification of mammalian microRNA host genes and transcription units. Genome Res 2004; 14: 1902-1910. (Pubitemid 39386503)
43. Raghunath M, Patti R, Bannerman P, et al., A novel kinase, AATYK induces and promotes neuronal differentiation in a human neuroblastoma (SH-SY5Y) cell line. Brain Res Mol Brain Res 2000; 77: 151-162. (Pubitemid 30317343)
44. Wong TS, Liu XB, Wong BY, et al., Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 2008; 14: 2588-2592.
45. Yu T, Wang XY, Gong RG, et al., The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. J Exp Clin Cancer Res 2009; 28: 64.
46. Sasai K, Romer JT, Kimura H, et al., Medulloblastomas derived from Cxcr6 mutant mice respond to treatment with a smoothened inhibitor. Cancer Res 2007; 67: 3871-3877. (Pubitemid 46762175)
47. Romer J, Curran T,. Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics. Cancer Res 2005; 65: 4975-4978. (Pubitemid 40827300)
48. Ruizi Altaba A, Sánchez P, Dahmane N,. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nature Rev Cancer 2002; 2: 361-372. (Pubitemid 37328949)
49. Cohen MM Jr,. The hedgehog signaling network. Am J Med Genet A 2003; 123A: 5-28. (Pubitemid 37309353)
50. Ferretti E, De Smaele E, Miele E, et al., Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. EMBO J 2008; 27: 2616-2627.
51. Rowe RG, Weiss SJ,. Navigating ECM barriers at the invasive front: the cancer cell-stroma interface. Annu Rev Cell Dev Biol 2009; 25: 567-595.
52. Nelson AR, Fingleton B, Rothenberg ML, et al., Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000; 18: 1135-1149. (Pubitemid 30123793)
53. Chambers AF, Matrisian LM,. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997; 89: 1260-1270. (Pubitemid 27371946)